ARTICLE | Clinical News
Birinapant: Phase Ib/IIa data
July 1, 2013 7:00 AM UTC
Data from 51 evaluable patients with relapsed or refractory metastatic colorectal cancer (mCRC) in an open-label, U.S. Phase Ib/IIa trial showed that once-weekly IV birinapant plus irinotecan for the ...